Oncology
Two distinct offerings: one non-medical wellness score on TwinMe, and one regulated clinical decision-assistance pathway available only where authorized.
Available now Cancer Risk Program
A non-medical wellness program that helps you understand modifiable lifestyle-linked risk patterns across six cancers, using lifestyle inputs, family history, wearable signals, and your metabolic lifestyle Bio-Signature.
Cancer Risk Program is a non-medical wellness score. It uses lifestyle inputs, family history, wearable signals, and metabolic lifestyle Bio-Signatures to estimate modifiable lifestyle-linked risk patterns. It does not detect cancer, does not screen for cancer, does not use cancer biomarkers, and does not replace clinical screening or medical advice.
It is NOT cancer screening. It does NOT detect cancer. It does NOT replace clinical screening.
Available only through participating physicians in authorized UAE clinical settings. Canada and U.S. clinical availability is pending Health Canada and FDA review. Cancer Screening Decision Assistance Tool (CDSS)
In collaboration with your health professional.
BioTwin's screening decision-assistance tool supports earlier and better-targeted screening conversations between patients and licensed healthcare professionals in authorized clinical settings. Canada and U.S. clinical availability is pending Health Canada and FDA review.
Clinical availability: BioTwin's cancer screening decision-assistance pathway is available only through participating physicians in authorized UAE clinical settings. Canada and U.S. clinical availability is pending Health Canada and FDA review. TwinMe is BioTwin's non-medical wellness experience.
It is a screening decision assistance tool. It is not a screening tool nor a diagnostic device.
More information → IMPORTANT.
The Cancer Risk Program available on TwinMe is a non-medical wellness program. It does not detect cancer, is not a screening tool, and does not replace clinical screening conversations with a licensed healthcare professional.
The Cancer Screening Decision Assistance Tool (CDSS) is a screening decision assistance tool intended to support, not replace, clinical judgment. It is available only through participating physicians in authorized UAE clinical settings. Canada and U.S. clinical availability is pending Health Canada and FDA review.
Any individual who notices symptoms or has a personal or family cancer history should consult a licensed healthcare professional. BioTwin tools are not a substitute for medical advice, diagnosis, or treatment.
